Jacobson, Peer B.
Mothe, Andrea
Levy, Aharon
Krakovsky, Michael
Hooker, Bradley A.
Zhang, Xiaomeng
Mollon, Jennifer
Mordashova, Yulia
Droescher, Mathias
Weiss, Sabine
Barghorn, Stefan
Dreher, Ingeborg
Awwad, Khader
Nimmrich, Volker
Huang, Lili
Fung, Emma
Buck, Wayne R.
Pfleeger, Kimberly
Ziemann, Adam
Smith, Elaine
Fox, Gerard B.
Tator, Charles H.
Gold, Michael
Funding for this research was provided by:
AbbVie
Article History
Received: 1 March 2023
Revised: 23 May 2023
Accepted: 26 May 2023
First Online: 16 June 2023
Declarations
:
: The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication. P.B.J. was an AbbVie employee when these studies were conducted. B.A.H, X.Z., J.M., Y.M., M.D., S.W., S.B., I.D., K.A., V.N., L.H., E.F., W.R.B., K.P., and E.S. are paid employees of AbbVie and may own AbbVie stock or stock options. A.Z. and M.G. were AbbVie employees at the time of the study. AM and CHT are employed by the University of Toronto, and served as consultants for these studies (no funding to disclose). AL and MK are employed by Pharmaseed Ltd. which AbbVie financially supported for these studies.